| dbo:abstract |
Elizabeth Eisenhauer is a Canadian oncologist who has spent a large portion of her career undertaking phase I and II trials of novel cancer therapies through her role as Director of the Investigational New Drug Program in the Canadian Cancer Trials Group. She received her Doctor of Medicine degree from Queen's University and was trained in internal medicine and hematology, obtaining fellowships from the Royal College of Physicians and Surgeons of Canada. Eisenhauer is an Emerita professor in the Department of Oncology at Queen's University, and was Department Head from 2012 to 2017. She has served on the board of the American Society of Clinical Oncology, National Cancer Institute of Canada (as its President), the European Organization for Research and Treatment of Cancer, and the Canadian Cancer Society. In 2012, she was awarded with the Queen Elizabeth II Diamond Jubilee medal for “her tremendous commitment to the advancement of cancer therapy, supportive care and prevention across Canada and internationally.” In 2015 she was elected as a fellow of the Royal Society of Canada and in 2017, she was inducted as an Officer of the Order of Canada. In 2021 she was awarded the Canada Gairdner Wightman Award. (en) |
| dbo:wikiPageID |
60841400 (xsd:integer) |
| dbo:wikiPageLength |
3121 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1083176051 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Queen's_University_at_Kingston dbr:Queen_Elizabeth_II_Diamond_Jubilee_Medal dbr:Royal_College_of_Physicians_and_Surgeons_of_Canada dbr:Royal_Society_of_Canada dbc:Canadian_oncologists dbc:Women_oncologists dbr:Internal_medicine dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbc:Fellows_of_the_Royal_Society_of_Canada dbc:Officers_of_the_Order_of_Canada dbc:Queen's_University_at_Kingston_alumni dbr:Doctor_of_Medicine dbr:American_Society_of_Clinical_Oncology dbr:Hematology dbr:Oncology dbr:Order_of_Canada dbr:Canada_Gairdner_Wightman_Award dbr:Canadian_Cancer_Society |
| dbp:wikiPageUsesTemplate |
dbt:Canada-academic-bio-stub dbt:Authority_control dbt:Orphan dbt:Reflist dbt:Short_description |
| dct:subject |
dbc:Canadian_oncologists dbc:Women_oncologists dbc:Living_people dbc:Year_of_birth_missing_(living_people) dbc:Fellows_of_the_Royal_Society_of_Canada dbc:Officers_of_the_Order_of_Canada dbc:Queen's_University_at_Kingston_alumni |
| rdf:type |
owl:Thing |
| rdfs:comment |
Elizabeth Eisenhauer is a Canadian oncologist who has spent a large portion of her career undertaking phase I and II trials of novel cancer therapies through her role as Director of the Investigational New Drug Program in the Canadian Cancer Trials Group. She received her Doctor of Medicine degree from Queen's University and was trained in internal medicine and hematology, obtaining fellowships from the Royal College of Physicians and Surgeons of Canada. (en) |
| rdfs:label |
Elizabeth Eisenhauer (en) |
| owl:sameAs |
wikidata:Elizabeth Eisenhauer https://global.dbpedia.org/id/9Rzz3 |
| prov:wasDerivedFrom |
wikipedia-en:Elizabeth_Eisenhauer?oldid=1083176051&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:Elizabeth_Eisenhauer |
| is dbo:wikiPageDisambiguates of |
dbr:Eisenhauer |
| is dbo:wikiPageWikiLink of |
dbr:Eisenhauer dbr:Canada_Gairdner_Wightman_Award |
| is foaf:primaryTopic of |
wikipedia-en:Elizabeth_Eisenhauer |